Earlier work with rats and our recent human studies demonstrate that oral exposure to dietary fats alters fat metabolism. Four studies are proposed to more fully characterize this phenomenom so that its physiological and public health significance can be established. Generally, these protocols will entail within-subject designs. The procedures will involve having subjects ingest a load of fat (as a milkshake or in capsules) and then receive various forms of oral stimulation. Blood samples will be collected at timed intervals for analysis of metabolic responses to the oral stimulation. In one study, the type of lipid contained in the fat load will be manipulated (saturated versis unsaturated, long-chained versus medium chained) to assess the effects of fat type on the response. In another study, the form of oral stimulation will be altered to include fat substitutes composed of protein, carbohydrate or fat. This will help to identify the effective stimulus for the effect. The third study will have subjects ingest the load as a milkshake (as is routinely done in fat challenge tests) with and without pleasant (sweet) and less pleasant (bitter) tastes to examine the role of taste in reported augmented postprandial triglyceride levels in trial wher sucrose or fructose are added to the lipid load. The fourth study will be conducted with individuals who have normal and elevated basal plasma triglyceride concentrations. There are preliminary reports of greater postprandial triglyceride excursions among individuals with high basal triglyceride levels. Given that postprandial lipid levels may be related to coronary heart disease risk, it is important to understand the factors that influence lipid metabolism. Oral factors are especially important with the increasing use of products containing compounds taht mimic the sensory properites of fats.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
27
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Robinson-Cohen, Cassianne; Bartz, Traci M; Lai, Dongbing et al. (2018) Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. J Am Soc Nephrol 29:2583-2592
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Srinivasan, Lakshmi; Page, Grier; Kirpalani, Haresh et al. (2017) Genome-wide association study of sepsis in extremely premature infants. Arch Dis Child Fetal Neonatal Ed 102:F439-F445
Gupta, Samir K; Yeh, Eunice; Kitch, Douglas W et al. (2017) Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s. J Antimicrob Chemother 72:2042-2048
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Patel, Yash R; Kirkman, M Sue; Considine, Robert V et al. (2017) Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis. J Diabetes Complications 31:605-610
Robarge, Jason D; Metzger, Ingrid F; Lu, Jessica et al. (2017) Population Pharmacokinetic Modeling To Estimate the Contributions of Genetic and Nongenetic Factors to Efavirenz Disposition. Antimicrob Agents Chemother 61:
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419

Showing the most recent 10 out of 767 publications